Singulex Announces CE Mark For Sgx Clarity System Post author:Sam Post published:April 2, 2017 Post category:BioPharma Life Sciences Jobs … Source: BioSpace You Might Also Like Envisia Therapeutics Releases Interim ENV515 (Travoprost XR) Phase II Data Demonstrating 11-Month Duration-Of-Action After A Single Dose In Patients With Glaucoma February 2, 2017 How Roche Fine-Tuned an Old Drug Under a New Name to Keep Making Profits August 23, 2017 Athenex, A US-China Cancer Company, Stages $66 Million U.S. IPO June 15, 2017
Envisia Therapeutics Releases Interim ENV515 (Travoprost XR) Phase II Data Demonstrating 11-Month Duration-Of-Action After A Single Dose In Patients With Glaucoma February 2, 2017